Variant report

Variant	esv3425461
Chromosome Location	chr5:178976371-178979219
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:582)
CpG islands
(count:854)
Chromatin interactive
region (count:29)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:582 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:178977590-178977818	HepG2	liver:	n/a	n/a
2	ARID3A	chr5:178977115-178977357	HepG2	liver:	n/a	n/a
3	ATF2	chr5:178976968-178977468	GM12878	blood:	n/a	n/a
4	ATF2	chr5:178977014-178977777	GM12878	blood:	n/a	n/a
5	BACH1	chr5:178977696-178978347	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr5:178976363-178976432	K562	blood:	n/a	n/a
7	BCLAF1	chr5:178977094-178977496	GM12878	blood:	n/a	chr5:178977430-178977439
8	BCLAF1	chr5:178977522-178978403	GM12878	blood:	n/a	chr5:178978060-178978073 chr5:178978272-178978285 chr5:178978064-178978077
9	BHLHE40	chr5:178977555-178978270	HepG2	liver:	n/a	chr5:178978066-178978082 chr5:178978012-178978028
10	BHLHE40	chr5:178976912-178978367	GM12878	blood:	n/a	chr5:178978066-178978082 chr5:178978012-178978028 chr5:178978259-178978275
11	BHLHE40	chr5:178977025-178978380	K562	blood:	n/a	chr5:178978066-178978082 chr5:178978012-178978028 chr5:178978259-178978275
12	CCNT2	chr5:178977542-178978403	K562	blood:	n/a	n/a
13	CEBPB	chr5:178976906-178978479	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr5:178978079-178978276	HepG2	liver:	n/a	n/a
15	CEBPB	chr5:178977272-178977473	K562	blood:	n/a	n/a
16	CEBPB	chr5:178977303-178977503	HepG2	liver:	n/a	n/a
17	CEBPD	chr5:178977500-178977868	HepG2	liver:	n/a	n/a
18	CEBPD	chr5:178977210-178978017	HepG2	liver:	n/a	n/a
19	CHD1	chr5:178977596-178977803	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD1	chr5:178976957-178977842	GM12878	blood:	n/a	n/a
21	CHD1	chr5:178978067-178978482	GM12878	blood:	n/a	n/a
22	CHD1	chr5:178978051-178978501	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD1	chr5:178977040-178977366	H1-hESC	embryonic stem cell:	n/a	n/a
24	CHD2	chr5:178977605-178977790	H1-hESC	embryonic stem cell:	n/a	n/a
25	CHD2	chr5:178977287-178978355	Hela-S3	cervix:	n/a	n/a
26	CHD2	chr5:178977193-178978368	GM12878	blood:	n/a	n/a
27	CHD2	chr5:178978085-178978277	K562	blood:	n/a	n/a
28	CHD2	chr5:178977417-178977880	K562	blood:	n/a	n/a
29	CREB1	chr5:178977079-178978466	GM12878	blood:	n/a	n/a
30	CREB1	chr5:178977473-178978294	A549	lung:	n/a	n/a
31	CREB1	chr5:178976917-178977858	GM12878	blood:	n/a	n/a
32	CTCF	chr5:178977160-178977310	AoAF	blood vessel:	n/a	n/a
33	CTCF	chr5:178977240-178977390	AoAF	blood vessel:	n/a	n/a
34	CTCF	chr5:178978218-178978348	GM12878	blood:	n/a	n/a
35	CTCF	chr5:178977905-178978325	K562	blood:	n/a	chr5:178978059-178978072
36	CTCF	chr5:178977320-178977470	HCPEpiC	choroid plexus:	n/a	n/a
37	CTCF	chr5:178977180-178977330	HBMEC	blood vessel:	n/a	n/a
38	CTCF	chr5:178977024-178977446	K562	blood:	n/a	n/a
39	CTCF	chr5:178977340-178977490	AG04449	skin:	n/a	n/a
40	CTCF	chr5:178978160-178978310	GM12871	blood:	n/a	n/a
41	CTCF	chr5:178977100-178977250	AG04450	lung:	n/a	n/a
42	CTCF	chr5:178977260-178977410	AG04449	skin:	n/a	n/a
43	CTCF	chr5:178978140-178978290	HCPEpiC	choroid plexus:	n/a	n/a
44	CTCF	chr5:178977140-178977290	HAc	cerebellar:	n/a	n/a
45	CTCF	chr5:178977160-178977310	HMF	breast:	n/a	n/a
46	CTCF	chr5:178978180-178978330	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr5:178976768-178976845	GM13976	blood:	n/a	n/a
48	CTCF	chr5:178976980-178977130	RPTEC	kidney:	n/a	n/a
49	CTCF	chr5:178978213-178978229	GM19239	blood:	n/a	n/a
50	CUX1	chr5:178976917-178977459	K562	blood:	n/a	n/a

(count:854 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:178977236-178977286	A549	lung:	n/a
2	chr5:178977398-178977448	NT2-D1	testis:	n/a
3	chr5:178977641-178977691	NT2-D1	testis:	n/a
4	chr5:178978234-178978284	HAEpiC	amniotic membrane:	n/a
5	chr5:178977521-178977571	AG10803	skin:	n/a
6	chr5:178977326-178977376	NB4	blood:	n/a
7	chr5:178977326-178977376	HCM	heart:	n/a
8	chr5:178978234-178978284	PANC-1	pancreas:	n/a
9	chr5:178977398-178977448	BJ	skin:	n/a
10	chr5:178977521-178977571	HRPEpiC	eye:	n/a
11	chr5:178977641-178977691	T-47D	breast:	n/a
12	chr5:178977641-178977691	MCF10A-Er-Src	breast:	n/a
13	chr5:178977406-178977456	IMR90	lung:	fetal
14	chr5:178977326-178977376	AG04449	skin:	fetal
15	chr5:178977236-178977286	PrEC	prostate:	n/a
16	chr5:178977236-178977286	NT2-D1	testis:	n/a
17	chr5:178977406-178977456	Jurkat	blood:	n/a
18	chr5:178978234-178978284	HCF	heart:	n/a
19	chr5:178977398-178977448	HRCEpiC	kidney:	n/a
20	chr5:178978460-178978510	SK-N-MC	brain:	n/a
21	chr5:178977398-178977448	NHDF-neo	bronchial:	n/a
22	chr5:178977181-178977231	NB4	blood:	n/a
23	chr5:178977123-178977173	CMK	blood:	n/a
24	chr5:178978234-178978284	SK-N-MC	brain:	n/a
25	chr5:178978234-178978284	HIPEpiC	eye:	n/a
26	chr5:178977375-178977425	T-47D	breast:	n/a
27	chr5:178977406-178977456	AG04449	skin:	fetal
28	chr5:178977236-178977286	NB4	blood:	n/a
29	chr5:178977181-178977231	HPAEpiC	pulmonary alveolar:	n/a
30	chr5:178977123-178977173	HEEpiC	esophagus:	n/a
31	chr5:178977375-178977425	MCF-7	breast:	n/a
32	chr5:178977648-178977698	SKMC	muscle:	n/a
33	chr5:178977641-178977691	HEK293	kidney:	embryo
34	chr5:178978460-178978510	HPAEpiC	pulmonary alveolar:	n/a
35	chr5:178977375-178977425	ovcar-3	ovarian:	n/a
36	chr5:178977181-178977231	CMK	blood:	n/a
37	chr5:178977641-178977691	GM12891	blood:	n/a
38	chr5:178977375-178977425	HCF	heart:	n/a
39	chr5:178978460-178978510	A549	lung:	n/a
40	chr5:178977648-178977698	PFSK-1	brain:	n/a
41	chr5:178978234-178978284	PFSK-1	brain:	n/a
42	chr5:178977648-178977698	NHDF-neo	bronchial:	n/a
43	chr5:178977375-178977425	SKMC	muscle:	n/a
44	chr5:178977648-178977698	ovcar-3	ovarian:	n/a
45	chr5:178977236-178977286	SK-N-SH_RA	brain:	n/a
46	chr5:178977394-178977444	NT2-D1	testis:	n/a
47	chr5:178977641-178977691	GM19239	blood:	n/a
48	chr5:178977375-178977425	GM12891	blood:	n/a
49	chr5:178977521-178977571	PrEC	prostate:	n/a
50	chr5:178977394-178977444	CMK	blood:	n/a

(count:29 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:178964680..178966401-chr5:178977965..178979894,2	K562	blood:
2	chr5:178976811..178980871-chr5:179039605..179043375,3	K562	blood:
3	chr1:110881782..110882370-chr5:178977392..178978012,2	Hela-S3	cervix:
4	chr5:178953283..178956112-chr5:178976067..178979094,3	MCF-7	breast:
5	chr5:178975834..178978833-chr5:179245271..179247079,2	K562	blood:
6	chr5:178978852..178982589-chr5:179047122..179052388,6	MCF-7	breast:
7	chr5:178976299..178979036-chr5:178987617..178989903,2	K562	blood:
8	chr5:178971437..178973246-chr5:178974311..178976700,2	K562	blood:
9	chr5:178977892..178980462-chr5:179104901..179106460,2	MCF-7	breast:
10	chr5:178976850..178979581-chr5:179125172..179127163,2	K562	blood:
11	chr5:178976591..178978128-chr5:179049452..179051597,2	MCF-7	breast:
12	chr5:178975801..178977799-chr5:178987617..178990258,3	K562	blood:
13	chr5:178976539..178978410-chr5:179046983..179049342,2	MCF-7	breast:
14	chr5:178977295..178978049-chrX:153718720..153719639,2	Hela-S3	cervix:
15	chr5:178975690..178977861-chr5:179029775..179032308,2	K562	blood:
16	chr5:178975751..178978306-chr5:178993914..178996502,2	MCF-7	breast:
17	chr5:178947804..178950473-chr5:178974779..178977233,2	MCF-7	breast:
18	chr5:178977541..178979171-chr5:179015422..179017966,2	K562	blood:
19	chr12:50135028..50135993-chr5:178977449..178978052,2	Hela-S3	cervix:
20	chr5:178976288..178979908-chr5:179158372..179161228,3	MCF-7	breast:
21	chr5:178975440..178984076-chr5:179047224..179053131,17	K562	blood:
22	chr5:178967564..178969306-chr5:178978047..178979581,2	K562	blood:
23	chr5:178976329..178981059-chr5:179123787..179127407,6	K562	blood:
24	chr5:178976464..178979366-chr5:179003151..179005535,3	MCF-7	breast:
25	chr5:178976757..178979190-chr5:180687275..180690244,2	K562	blood:
26	chr5:178961944..178964885-chr5:178975318..178977306,2	MCF-7	breast:
27	chr15:22833249..22833980-chr5:178977502..178978069,2	Hela-S3	cervix:
28	chr17:1619473..1620028-chr5:178976878..178977774,2	Hela-S3	cervix:
29	chr5:178975871..178983601-chr5:179047224..179052413,15	K562	blood:

No data

Variant related genes	Relation type
RUFY1	TF binding region
RUFY1	CpG island
ENSG00000244945	chromatin interactions
ENSG00000183718	chromatin interactions
ENSG00000225051	chromatin interactions
ENSG00000139644	chromatin interactions
ENSG00000167716	chromatin interactions
ENSG00000153575	chromatin interactions
ENSG00000127022	chromatin interactions
ENSG00000253520	chromatin interactions
ENSG00000251545	chromatin interactions
ENSG00000227963	chromatin interactions
ENSG00000186594	chromatin interactions
ENSG00000176783	chromatin interactions
ENSG00000169045	chromatin interactions
ENSG00000161021	chromatin interactions
ENSG00000161011	chromatin interactions
ENSG00000162775	chromatin interactions
ENSG00000248275	chromatin interactions
ENSG00000126903	chromatin interactions

Extended variants
information (count: 116 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:116 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560299414	chr5:178976386-178976387	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
2	rs4700836	chr5:178976393-178976394	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs546121730	chr5:178976424-178976425	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
4	rs564233232	chr5:178976444-178976445	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
5	rs375854005	chr5:178976447-178976448	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
6	rs541068745	chr5:178976479-178976480	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
7	rs545839789	chr5:178976533-178976534	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
8	rs61416469	chr5:178976587-178976588	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
9	rs398084689	chr5:178976591-178976592	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
10	rs112589907	chr5:178976594-178976595	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
11	rs141677705	chr5:178976616-178976617	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
12	rs79951335	chr5:178976646-178976647	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
13	rs150512199	chr5:178976671-178976672	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
14	rs369587357	chr5:178976696-178976697	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
15	rs568123309	chr5:178976702-178976703	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
16	rs201298746	chr5:178976711-178976712	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
17	rs199806389	chr5:178976712-178976713	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
18	rs529011367	chr5:178976717-178976718	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
19	rs139439136	chr5:178976733-178976734	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
20	rs534885756	chr5:178976736-178976737	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
21	rs565563148	chr5:178976748-178976749	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
22	rs373968956	chr5:178976750-178976751	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
23	rs562305524	chr5:178976753-178976754	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
24	rs375659528	chr5:178976765-178976766	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
25	rs371053528	chr5:178976768-178976769	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
26	rs570850378	chr5:178976780-178976781	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
27	rs538047952	chr5:178976785-178976786	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
28	rs149751432	chr5:178976793-178976794	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
29	rs114579581	chr5:178976803-178976804	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
30	rs541977539	chr5:178976809-178976810	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
31	rs375226354	chr5:178976835-178976836	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
32	rs181737585	chr5:178976880-178976881	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
33	rs116050524	chr5:178976896-178976897	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
34	rs78599810	chr5:178976912-178976913	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
35	rs146262019	chr5:178976913-178976914	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
36	rs537290690	chr5:178976959-178976960	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
37	rs10074573	chr5:178976966-178976967	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs531664482	chr5:178976986-178976987	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
39	rs116102514	chr5:178976991-178976992	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
40	rs115659741	chr5:178977000-178977001	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
41	rs528955161	chr5:178977045-178977046	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
42	rs116769309	chr5:178977058-178977059	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
43	rs558883145	chr5:178977066-178977067	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
44	rs560536161	chr5:178977127-178977128	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
45	rs144949521	chr5:178977141-178977142	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
46	rs529324898	chr5:178977142-178977143	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
47	rs78185536	chr5:178977155-178977156	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
48	rs116183434	chr5:178977179-178977180	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
49	rs551010961	chr5:178977220-178977221	Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
50	rs548035545	chr5:178977227-178977228	Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:511 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:178958000-178976800	Weak transcription	Fetal Intestine Small	intestine
2	chr5:178958000-178977000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr5:178963600-178976400	Weak transcription	Osteobl	bone
4	chr5:178972000-178976400	Weak transcription	Primary monocytes fromperipheralblood	blood
5	chr5:178972000-178976400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr5:178972000-178976400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr5:178972000-178976600	Weak transcription	Fetal Thymus	thymus
8	chr5:178972000-178976600	Weak transcription	Monocytes-CD14+_RO01746	blood
9	chr5:178972000-178976800	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr5:178972200-178976800	Weak transcription	Primary hematopoietic stem cells	blood
11	chr5:178972400-178976600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
12	chr5:178972400-178976600	Weak transcription	Rectal Mucosa Donor 31	rectum
13	chr5:178972600-178976600	Weak transcription	GM12878-XiMat	blood
14	chr5:178973800-178976600	Weak transcription	Primary B cells from peripheral blood	blood
15	chr5:178974200-178976400	Weak transcription	H1 Cell Line	embryonic stem cell
16	chr5:178974200-178976400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
17	chr5:178975000-178976800	Enhancers	Adipose Nuclei	Adipose
18	chr5:178975200-178976600	Weak transcription	HUES64 Cell Line	embryonic stem cell
19	chr5:178975400-178976400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
20	chr5:178975600-178976600	Enhancers	Lung	lung
21	chr5:178975600-178977000	Weak transcription	Placenta Amnion	Placenta Amnion
22	chr5:178975800-178976400	Weak transcription	Fetal Muscle Trunk	muscle
23	chr5:178976000-178976400	Flanking Active TSS	HepG2	liver
24	chr5:178976200-178976400	Enhancers	Muscle Satellite Cultured Cells	--
25	chr5:178976200-178976600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr5:178976200-178976600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr5:178976200-178976600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr5:178976200-178976600	Enhancers	Dnd41	blood
29	chr5:178976200-178976800	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr5:178976200-178976800	Enhancers	HUES48 Cell Line	embryonic stem cell
31	chr5:178976200-178976800	Enhancers	Primary B cells from cord blood	blood
32	chr5:178976200-178976800	Enhancers	Fetal Muscle Leg	muscle
33	chr5:178976200-178976800	Enhancers	Skeletal Muscle Male	skeletal muscle
34	chr5:178976200-178976800	Enhancers	Thymus	Thymus
35	chr5:178976200-178977000	Enhancers	Liver	Liver
36	chr5:178976200-178977000	Enhancers	NHDF-Ad	bronchial
37	chr5:178976200-178977200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
38	chr5:178976200-178977200	Flanking Active TSS	Hela-S3	cervix
39	chr5:178976400-178976600	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr5:178976400-178976600	Enhancers	iPS-18 Cell Line	embryonic stem cell
41	chr5:178976400-178976600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr5:178976400-178976600	Enhancers	Primary neutrophils fromperipheralblood	blood
43	chr5:178976400-178976600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr5:178976400-178976600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr5:178976400-178976600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr5:178976400-178976600	Enhancers	Fetal Kidney	kidney
47	chr5:178976400-178976600	Enhancers	NHLF	lung
48	chr5:178976400-178976600	Enhancers	Osteobl	bone
49	chr5:178976400-178976800	Enhancers	H1 Cell Line	embryonic stem cell
50	chr5:178976400-178976800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links